Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
46.48
+0.41 (0.89%)
At close: Dec 5, 2025, 4:00 PM EST
46.50
+0.02 (0.04%)
After-hours: Dec 5, 2025, 6:27 PM EST
Vaxcyte Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6,085 | 10,203 | 5,976 | 3,787 | 1,256 | 1,354 | |
| Market Cap Growth | -43.56% | 70.74% | 57.79% | 201.58% | -7.24% | - | |
| Enterprise Value | 4,458 | 8,050 | 4,724 | 3,445 | 978 | 957 | |
| Last Close Price | 46.48 | 81.86 | 62.80 | 47.95 | 23.79 | 26.57 | |
| PB Ratio | 2.09 | 3.09 | 4.82 | 3.97 | 4.42 | 3.91 | |
| P/TBV Ratio | 2.10 | 3.09 | 4.82 | 3.97 | 4.42 | 3.91 | |
| Debt / Equity Ratio | 0.03 | 0.02 | 0.02 | 0.02 | 0.06 | - | |
| Quick Ratio | 8.56 | 12.61 | 7.46 | 23.08 | 8.61 | 8.25 | |
| Current Ratio | 8.83 | 12.76 | 7.54 | 23.26 | 8.93 | 8.30 | |
| Return on Equity (ROE) | -20.83% | -20.41% | -36.67% | -36.12% | -31.78% | -44.58% | |
| Return on Assets (ROA) | -15.07% | -14.47% | -24.23% | -21.82% | -18.07% | -24.42% | |
| Return on Capital (ROIC) | -15.79% | -15.32% | -26.10% | -22.82% | -20.04% | -27.97% | |
| Return on Capital Employed (ROCE) | -27.30% | -16.90% | -37.10% | -24.10% | -35.10% | -25.90% | |
| Earnings Yield | -10.80% | -4.55% | -6.73% | -5.90% | -7.97% | -6.59% | |
| FCF Yield | -10.20% | -5.60% | -6.10% | -4.66% | -10.19% | -3.53% | |
| Buyback Yield / Dilution | -19.29% | -25.57% | -49.75% | -24.95% | -75.73% | -678.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.